Antonia DePace

Recent results may lead to more checkpoint inhibitor options and lower treatment prices, giving accessibility to more patients with lung cancer worldwide.

Twenty years after 9/11, a retired firefighter reflects on the weeks following the attacks, as well as his own diagnosis of lung cancer six years later, in a newly published book.

Looking deeper into mortality rates highlights the importance of eliminating disparities in lung cancer and expanding screening eligibility for at-risk populations.

Two new FDA approvals for patients with lung cancer and EGFR exon 20 insertion mutations have given the subset its first targeted therapies.

One cancer survivor's garden helped her to cope and stay active during diagnosis, through treatment and into remission.

More than 10 years of follow-up data have shown that combining Herceptin with chemotherapy is safer and more effective than chemotherapy alone in this patient population.

Several breast cancer survivors share how they stay mentally strong while living with breast cancer.

A new T-cell therapy can be highly effective in treating BKV-associated hemorrhagic cystitis while minimizing side effects.

A three-time acute lymphoblastic leukemia survivor became a bone marrow transplant nurse and now helps other patients with the same diagnosis.

A patient turned to yoga during treatment for breast cancer and is now helping others do the same.

Talking with a doctor about costly cancer treatments and being frank with health care teams can ease financial distress for patients with cancer.

Yvonne Orji, actress and comedian from HBO’s “Insecure” discussed the racial disparities for Black women who receive a diagnosis of triple-negative breast cancer.

A mother of three who received a diagnosis of stage 4 breast cancer right before the pandemic shares what her must-have comfort and entertainment items are in her treatment bag.

Gleevec was approved by the FDA in 2001. The groundbreaking oral drug has since been a lifesaver for many patients with chronic myeloid leukemia.

After receiving a diagnosis of multiple myeloma, a patient relied on the Multiple Myeloma Research Foundation for information and is becoming part of the conversation.

A fixed-duration treatment regimen may result in better outcomes and less time in the hospital for patients with CLL.

Meet Jazmine Sullivan: singer-songwriter, BET award winner and breast cancer advocate.

Determining body composition – a more nuanced approach to predicting survival outcomes in patients with breast cancer – may be a more accurate indicator than BMI, according to one study.

Many patients with cancer experience challenges with sexual intimacy. Body image, self-esteem, vaginal health and a positive mindset all come into play.

Side effects from early-onset menopause from medical treatments may be mitigated with hormone replacement therapy.

While sparking a conversation about cancer risk after a family diagnosis is hard, one expert said that there are benefits — especially when using specific tactics.

One oncologist highlighted the knowledge base of the immunotherapy and targeted therapy and how they interact with cancer cells.

Getting rid of the "blanket statement" and looking deeper into genetics may allow patients with cancer who are older than 60 years to become eligible for immunotherapy, highlighting the importance of further research on the topic.

Geographic disparities at the state-level are leading to increased rates of death from lung cancer, according to an expert.

Results from the study highlight the need to organize better screening and treatment plans for patients with liver cancer coinfected with hepatitis B, hepatitis C or HIV.

The antibody drug conjugate could provide patients with symptomatic relief, along with manageable side effects.

Children younger than five years old may have an increased risk for hearing loss from cisplatin-based therapies compared with older children, highlighting the potential need for more consistent monitoring for hearing loss in children with cancer.

The tome also reflects on his own diagnosis of cancer and how it influenced his practice.

The FDA approval of Cabometyx was based on results that showed that the drug was associated with improved outcomes in patients with radioactive iodine–refractory locally advanced or metastatic differentiated thyroid cancer.

The eligible age of 65 years for Medicare may be discouraging patients from getting screenings and tests as they wait for more health coverage.